DISEASE INDICATIONS: Urothelial Carcinoma, Breast Cancer, Lung Cancer
MANUFACTURER: Roche Registration Limited
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
It belongs to a class of drugs known as immune checkpoint inhibitors and has been approved for the treatment of multiple types of cancer.
